The European Society of Human Genetics
is a non-profit organization. Its aims are to promote research in basic and applied human and medical genetics, to ensure high standards in clinical practice and to facilitate contacts between all persons who share these aims, particularly those working in Europe. The Society will encourage and seek to integrate research and its translation into clinical benefits and professional and public education in all areas of human genetics.
The 2015 registration process for the European registered Clinical Laboratory Geneticist (ErCLG) by the European Board of Human Genetics has started and is open until September 15, 2015.
Information on eligibility criteria, required documents and the submission process can be found here.
Applications can be made exclusively via the new online submission tool.
View the details of the joint ESC & ESHG Session during the European Congress of Cardiology, August 29 - September 3, 2015.
With great sadness we have learned that on june 14, Professor Richard (Dick) Cotton died peacefully in Melbourne.
We wish to thank almost 2,700 participants and over 145 exhibiting companies and their staff for having attended the ESHG Conference in Glasgow.
We hope to see you in Barcelona in May 2016.
View the following sessions as web-cast:
- Opening Plenary Session - selected talks
- ESHG-ASHG Building Bridges Symposium on "Genetic testing in children"
- Plenary Debate: "Should all geneticists have their genome sequenced?"
- Mendel Lecture
- ESHG Award Lecture
Videos are now available as on-demand download.
We would be interested to know, if you have recently been thoroughly impressed by one or more speakers you have seen at a meeting (obviously outside the ESHG Annual meeting), both in terms of being an excellent speaker and of presenting excellent science.
We look very much forward to receiving your input at your earliest convenience, in order to discuss it at the next SPC meeting end of June, but we will keep the online form open over the whole year and are equally happy to receive a feedback whenever you experienced a great talk at a meeting.
Thank you very much!
The winners of the DNA Day 2015 Essay Contest have been announced!
ASHG and ESHG Issue Position Statement on Non-Invasive Prenatal Screening
Two of the world’s largest professional societies of human geneticists have issued a joint position statement on the promise and challenges of non-invasive prenatal testing (NIPT), a new procedure to test blood drawn from pregnant mothers for Down syndrome and other chromosomal disorders in the fetus. The document addresses the current scope of and likely future improvements in NIPT technology, ways it may best fit with existing prenatal screening tools and protocols, options and priorities in its implementation, and associated social and ethical issues.
Sequencing technologies generate data on the entire sequence of the human genome for a decreasing price at increasing speed. This has increased the accessibility of using whole-genome sequencing and whole-exome sequencing approaches for analysis in both the research and clinical contexts.
The ESHG has issued recommendations.
This leaflet gives patients information about genetic tests that target many different genes at once. The information may help you to decide whether or not to have the test and help you to understand the results.
Recent amendments to the proposed Regulation on In Vitro Diagnostic Medical Devices (IVDs) currently before the European Parliament will restrict the rights of patients and doctors to carry out essential genetic testing, says the European Society of Human Genetics (ESHG) today (Monday 7 April 2014). Furthermore, an independent legal opinion now shows that the European Union (EU) has no competence to enact the Regulation as amended by the Parliament.
In a letter published in the journal Science on 30 August, Professor Martina Cornel, chair of the Professional and Public Policy Committee of ESHG and colleagues call for restraint in the use of diagnostic testing based on whole-genome sequencing.
The decision by the US Supreme Court to rule that human genes cannot be patented has important implications for patients and for science.